Dr. Steven E. Katz, MD

Dr. Katz practices at Ohio ENT and Allergy Physicians in Columbus, Ohio.

Dr. Katz's NPI, 1518906866, was assigned on June 5, 2006. Dr. Katz graduated from Ohio State University College of Medicine in 1990. Dr. Katz holds Ohio license 35061949.

Dr. Katz's primary practice is Ohio ENT and Allergy Physicians, at 974 Bethel Rd, Columbus, OH 43214 in Franklin County. The practice phone is (614) 273-2230.

Dr. Katz's primary practice is Ohio ENT and Allergy Physicians in Columbus, Ohio. Dr. Katz is also affiliated with OhioHealth Riverside Methodist Hospital. The medical group on file is Ohio ENT & Allergy Physicians. Dmand AI also links Dr. Katz to 4 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Katz practices, 6 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Katz's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Katz is licensed in Ohio.

CMS data shows 5,100 Medicare services from Dr. Katz across 11 procedure codes in 2024, for 549 Medicare patients. Medicare paid $98,322 for them.

CMS counts 549 Medicare patients who saw Dr. Katz in 2024. The largest group is 65 to 74, with 261 patients. 74% of them have high blood pressure, and 71% have high cholesterol. 9% are also on Medicaid. Their average risk score is 1.34, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Katz's median patient age at 63, with 66% women.

In 2024, Dr. Katz wrote 1,557 Medicare Part D claims for 408 patients. 63% of them were for generic drugs. CMS names the drug for 1,395 of them, across 31 drugs with 11 or more claims each, at $1,573,494 in total drug cost. In 2023, CMS named 1,112 claims across 27 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Katz for performance year 2024, reported as part of a group. Dr. Katz accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 9 papers to Dr. Katz, published from 2011 to 2023. The most frequent topics are Aortic Valve Insufficiency, Diagnosis, Differential and Intracranial Pressure. Dr. Katz has published most often in Orbit. Dr. Katz's most frequent co-authors are Atif Ben Collins, MD, Juan Crestanello, MD and Chigozirim Ekeke, MD.

Dmand AI links Dr. Katz to 2 clinical trials. Conditions studied include Optic Neuropathy, Ischemic, Pseudotumor Cerebri and Intracranial Hypertension.

CMS Open Payments shows 1,151 general payments to Dr. Katz from 34 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 53% of the total. Horizon Pharma plc paid the most, $124,998.

Dr. Katz graduated from Ohio State University College of Medicine in 1990.